In summary, the findings presented here increase our understanding of the cellular mechanisms increasing SERT function that may identify potential therapeutic approaches to manage GI disorders where SERT is dysregulated (such as infectious diarrhea and IBD). The gene discussed is SLC6A4; the disease is inflammatory bowel disease.